Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Clinical trial NCT01491529 · COMPLETED
Trial details
- NCT number
- NCT01491529
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2013-04-01
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.